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ABSTRACT
Background In 2011, the Netherlands implemented a
national policy that ensured that health insurance
companies reimbursed behavioural counselling for
smoking cessation or the combination of behavioural
counselling with pharmacological therapy.
Objective To examine the real-world impact of a
national reimbursement policy and accompanying media
attention on use of cessation treatment and on smoking
cessation.
Methods We used a four-wave longitudinal survey
among 2763 adult smokers that started in September
2010 and was repeated at approximately 3 month
intervals until June 2011. Two survey waves were
conducted before the implementation of the policy and
two survey waves after.
Findings There were significant increases in quit
attempts (among moderate-to-heavy smokers) and in
quit success (among all smokers) following the
implementation of the reimbursement policy and the
media attention. Use of behavioural counselling did not
increase, while use of pharmacological therapy without
behavioural counselling (unreimbursed treatment)
increased among moderate-to-heavy smokers. Attention
to media about the reimbursement was significantly
associated with more quit attempts and more quit
success. Awareness of the policy was significantly
associated with more use of reimbursed treatment
among all smokers, while attention to the media
coverage was only significantly associated with more use
of reimbursed treatment among moderate-to-heavy
smokers. Awareness/attention variables were not
significantly associated with use of unreimbursed
treatment.
Conclusions It seems that a national reimbursement
policy for smoking cessation treatment that is
accompanied by media attention can increase cessation.
Our findings suggest that this increase can (partly) be
ascribed to the media attention that accompanied the
policy implementation.
INTRODUCTION
The Framework Convention on Tobacco Control is
the first international treaty in the domain of public
health.1 Article 14 of the Framework Convention
on Tobacco Control states that parties to the treaty
shall take effective measures to promote smoking
cessation and should facilitate accessibility and
affordability of treatment for tobacco dependence.
In the guidelines of Article 14, countries are urged
to make efficacious cessation treatment available,
where possible free of charge or at an affordable
cost.2 A recent review concluded that financial
reimbursement of smoking cessation treatment can
increase the use of nicotine replacement therapy,
prescription medications and behavioural counsel-
ling and can stimulate smoking cessation attempts
and success.3 However, because this evidence
comes from experimental studies conducted under
controlled research conditions, this is less inform-
ative about the real-world effectiveness of reim-
bursing cessation treatment. The current study
examines whether a national reimbursement policy
increased the use of cessation treatment and stimu-
lated smoking cessation in the general population
of smokers.
Previous studies about the real-world effective-
ness of national reimbursement policies for
smoking cessation treatment have emerged mainly
from the UK. The UK National Health Service
Stop Smoking Services have offered free of charge
behavioural support and medications for smoking
cessation for more than 10 years.4 Evaluation
studies have focused on changes in use of the ser-
vices when they were already implemented,4 5
regional and sociodemographic variations in use6–8
and the real-world effectiveness of the received ces-
sation treatment.9 10 However, additional studies
are needed that compare the situation before and
after countries implement a national reimbursement
policy.
The Netherlands implemented a national policy
for reimbursement of smoking cessation treatment in
January 2011. Each smoker was eligible for full reim-
bursement of one smoking cessation programme per
year. A smoking cessation programme consisted of
multisession evidence-based behavioural counselling
(group, face-to-face or telephonic counselling) and, if
required, pharmacological therapy (nicotine replace-
ment therapy or prescription medications).
Pharmacological therapy was only reimbursed when
smokers also participated in behavioural counselling.
The Netherlands had a national quitline that offered
multisession evidence-based behavioural counselling
and, thus, all smokers in the Netherlands had access
to reimbursable cessation treatment.11 The reim-
bursement was paid only after spending the manda-
tory deductible of €170 per year for any healthcare
costs. This means that smokers were only fully reim-
bursed when they had completed their deductible.
Smokers could get the reimbursement by claiming
Research paper



















this from their health insurance company. In the Netherlands,
health insurance coverage is statutory and only 1% of the popula-
tion is uninsured.12
The introduction of the new reimbursement policy in the
Netherlands was accompanied by media attention. Most notably,
a media campaign was created by the Dutch Expert Centre on
Tobacco Control (STIVORO) and the Dutch Cancer Society to
communicate to the public that smoking cessation treatment will
be reimbursed from 2011. The campaign was funded by the
Netherlands Organization for Health Research and Development
(ZonMw) and the Dutch Cancer Society, it ran from December
2010 to January 2011 and campaign exposure among smokers
was around 80%.13 The campaign message was that it is possible
to ‘really’ quit smoking if you use the ‘right’ cessation treatment
(nicotine replacement therapy, prescription medications and
behavioural counselling). It was expected that this campaign
message would help increase the use of reimbursed smoking ces-
sation treatment and the number of quit attempts. Other media
attention included commercial advertisements from pharmaceut-
ical companies and information about the policy in news stories
that were published in several media.
Smoking prevalence in the Netherlands has fluctuated between
27% and 28% from 2004 to 2010, with higher levels of smoking
among lower educated groups.14 In 2010, pharmacological
therapy was the most commonly used smoking cessation treatment
in the Netherlands but few smokers used a combination of
pharmacological therapy and behavioural counselling.15 The
Dutch clinical guideline for the treatment of tobacco addiction
recommends pharmacological therapy for moderate-to-heavy
smokers, that is, those who smoke 10 or more cigarettes per day
(CPD), in addition to behavioural counselling.16 In concordance
with this recommendation, a recent study showed that Dutch
moderate-to-heavy smokers (71% of all smokers in the
Netherlands17) are more likely to receive advice from their general
practitioner to use pharmacological therapy compared with light
smokers.17 Therefore, it is important to examine effects separately
for light and moderate-to-heavy smokers.
This longitudinal study examined whether there was an
increase in smoking cessation and use of treatment after the
implementation of the policy and the media coverage in the
Netherlands. Furthermore, we related measures of awareness of
the policy and attention to the media coverage to changes in
smoking cessation and use of cessation treatment in order to
attempt to disentangle which effects were associated with the
policy and which effects with the media attention. Finally, we




Longitudinal data was used from a four-wave web survey that
started in September 2010 and was repeated at approximately
3 month intervals until June 2011, in the Netherlands. This
data was originally collected to evaluate the impact of the media
campaign about the reimbursement policy.13 The study had two
survey waves before the start of the media campaign and the
reimbursement policy and two survey waves afterwards. See
figure 1 for the exact fieldwork periods per survey wave.
A representative sample of smokers aged 18 years and older
was recruited through the research firm MarketResponse. In
total, 4338 potential respondents were asked to participate,
resulting in 2763 respondents (64%) in wave 1 of the web
survey. The follow-up surveys were sent to all respondents who
participated in wave 1. At wave 2, 1959 respondents (71%)
took part. At wave 3, 1872 respondents (68%) participated.
Finally, at wave 4, 1609 respondents (58%) participated. In
total, 1216 respondents (44%) participated in all four waves.
Measurements
The surveys included questions about background character-
istics, smoking characteristics, use of smoking cessation treat-
ment, smoking cessation behaviour, awareness of the
reimbursement policy and attention to media coverage. Survey
questions were adapted from previous population studies on
smoking cessation.18 19 The surveys took approximately
8–10 min to complete.
Respondents were asked about their gender, age, education
and number of CPD. Age was categorised into 18 years to 39
years, 40 years to 54 years, and 55 years and older. Education
was categorised into three levels: low (primary education and
lower prevocational secondary education), moderate (middle
prevocational secondary education and secondary vocational
education) and high (senior general secondary education, (pre-)
university education, and higher professional education).
Number of CPD was categorised into less than 10 CPD (light
smokers) versus 10 or more CPD (moderate-to-heavy smokers).
Awareness of the reimbursement policy was measured by
asking respondents ‘Is evidence-based smoking cessation treat-
ment reimbursed by all health insurance companies?’
Respondents could answer this question with ‘Yes’ (1) or ‘No’
(0). Attention to media coverage about the reimbursement policy
was measured with the question ‘How often have you heard any-
thing in the media about the reimbursement of smoking cessation
treatment by health insurance companies in the last 3 months?’
Answering categories ranged from ‘Never’ (0) to ‘Often’ (3).
Quit attempts were measured by asking whether respondents
made any attempt to quit smoking in the last 3 months.
Respondents who attempted to quit smoking were asked
whether they were smoking again or whether they were still
quit. Respondents, who reported to be still quit, were cate-
gorised as successful quitters. This measure of quit success is not
available for the first survey wave, because the sample contained
only current smokers at baseline.
Use of cessation treatment in the past 3 months was measured
by asking respondents whether they used any of the following:
nicotine replacement therapy (eg, patches or gum), prescription
medications (eg, bupropion or nortriptyline), behavioural coun-
selling (eg, by their general practitioner, at a smoking cessation
clinic or telephonic coaching) or other cessation treatment (not
specified). Respondents who used a combination of nicotine
replacement therapy or medications with behavioural counsel-
ling or who used only behavioural counselling were all consid-
ered eligible for reimbursement (further referred to as
‘reimbursed cessation treatment’). Respondents who used nico-
tine replacement therapy or medications without behavioural
counselling are referred to as using ‘unreimbursed cessation
treatment’.
Analyses
Analyses were performed with SPSS V.19.0. Data were weighted
by age, gender and region to be more representative of the
smokers’ population in the Netherlands.
Generalised estimating equations (GEE) analyses20 21 were
performed to assess whether quit attempts, quit success, use of
reimbursed treatment and use of unreimbursed treatment
changed between the four survey waves. GEE extends multivari-
ate regression analyses to longitudinal analyses of repeated mea-
sures. We used binomial variations for all models, the logit link
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and an unstructured correlation structure. Quit attempts, quit
success, use of reimbursed treatment and use of unreimbursed
treatment were the dependent variables, as measured at each of
the four survey waves. Independent variables were awareness of
the reimbursement policy and attention to media coverage
about the reimbursement policy, also measured at each wave.
Control variables were gender, age group, educational level and
number of CPD, as measured at baseline. Survey wave was
designated as the repeated measure variable. Separate models
were estimated in which the first survey wave was the reference
category and in which the second survey wave was the reference
category in order to gain more insight into when changes in the
outcome measures occurred. Additional models were estimated
that also contained interactions of number of CPD (light vs




Of the respondents of the baseline survey (unweighted data, not
shown in tables), 46% were male. Most respondents fell in the
age group 40–54 years (42%) or 55 years and older (39%).
Most respondents had a moderate educational level (39%),
while the low and high educational groups were about equal.
There were considerably more moderate-to-heavy smokers
(75%) than light smokers (25%).
Differential attrition
Respondents from the current study who were followed up
were compared with those who were not followed up to test for
differential attrition (unweighted data, not shown in tables).
Respondents from the youngest age group (18–39 years old)
were significantly less likely to participate in the fourth survey
than respondents from the older age groups (χ2 (2)=141.00,
p<0.001). Furthermore, respondents with a moderate educa-
tional level were less likely to participate in the fourth survey
than respondents with a low educational level (χ2 (2)=14.32,
p<0.001). These attrition effects for age group and educational
level were also statistically significant in the second and third
waves of the study and they have become larger with each wave.
Respondents who were followed up and who were not followed
up did not differ in gender distribution and number of CPD
(light vs moderate-to-heavy smokers).
Awareness of policy and attention to media
As can be seen in table 1, awareness of the reimbursement
policy increased with each wave (all p<0.001) from 15% at
wave 1 to 48% at wave 4. Attention to media coverage about
the reimbursement policy increased until the third wave (all
p<0.001). Between wave 3 and wave 4 there was a small statis-
tically significant decrease (p=0.030) in the attention to media
coverage about the reimbursement policy.
Quit attempts
Of all smokers, 11% reported to have attempted to quit
smoking in the last 3 months at wave 1 and 10% at wave 2
(table 1). At wave 3, 14% reported this and at wave 4, 15%.
Only the increase between wave 2 and wave 3 was statistically
significant (p<0.001).
The GEE analysis in table 2 revealed a statistically significant
increase in quit attempts at wave 3 (OR=1.33, 95% CI 1.13 to
1.56) and wave 4 (OR=1.47, 95% CI 1.24 to 1.74) compared
with wave 1. When wave 2 was taken as a reference category
(not shown in tables), the increase in quit attempts at wave 3
(OR=1.31, 95% CI 1.12 to 1.53) and wave 4 (OR=1.45, 95%
CI 1.22 to 1.72) remained statistically significant. Also shown in
table 2 is that attention to media about the reimbursement
policy was significantly associated with more quit attempts
(OR=1.18, 95% CI 1.10 to 1.27).
Additionally, using wave 1 as the reference category, a statistic-
ally significant interaction was found between number of CPD
(light vs moderate-to-heavy smokers) and the increase in attempts
to quit smoking at the third survey wave (OR=1.48, 95% CI 1.06
to 2.08) (table 3). Analyses stratified by number of CPD (not
shown in tables) revealed that the increase in attempts to quit
smoking between wave 1 and wave 3 was statistically significant
only among moderate-to-heavy smokers. Light smokers were sig-
nificantly more likely to attempt to quit smoking than
Figure 1 Timeline of September 2010 until June 2011 with survey waves, reimbursement policy and media campaign.
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moderate-to-heavy smokers at the first and second survey waves,
but this difference was no longer statistically significant at the third
and fourth survey waves due to an increase in quit attempts among
moderate-to-heavy smokers.
Quit success
Of all wave 1 smokers, 3% reported to have quit smoking suc-
cessfully at wave 2 (table 1). At wave 3, this doubled to 6% and
at wave 4 it was 8%. The increase between wave 2 and wave 3












Awareness of the reimbursement policy (% yes) 15.4 22.6*** 39.6*** 47.5***
Attention to media coverage about the reimbursement policy† (mean, SD) 0.40 (0.78) 0.48 (0.83)*** 0.87 (0.98)*** 0.81 (0.96)*
Smoking cessation attempt (% yes) 10.6 10.4 14.2*** 15.0
Smoking cessation success (% yes) - 3.3 6.3*** 8.0
Use of pharmacological therapy with behavioural counselling or behavioural counselling only‡
(% yes)
0.7 0.6 1.0 0.9
Use of pharmacological therapy without behavioural counseling§ (% yes) 1.9 1.8 2.9* 3.6
All smokers who tried to quit smoking
Smoking cessation success (% yes) – 31.6 42.7** 52.1
Use of pharmacological therapy with behavioural counselling or behavioural counselling only
(% yes)
6.6 5.6 6.8 5.6
Use of pharmacological therapy without behavioural counselling (% yes) 17.9 17.4 19.3 22.6
*p<0.05, **p<0.01, ***p<0.001 (difference with the previous wave).
†On a scale from 0 to 3.
‡Reimbursed cessation treatment.
§Unreimbursed cessation treatment.
Table 2 Generalised estimating equations analyses of predictors of attempts to quit smoking, quit success, use of reimbursed treatment and
















Male 1.00 1.00 1.00 1.00
Female 1.18 (0.98 to 1.42) 1.13 (0.84 to 1.53) 1.03 (0.58 to 1.85) 0.97 (0.67 to 1.40)
Age group
18–39 years old 1.00 1.00 1.00 1.00
40–54 years old 1.25 (0.97 to 1.62) 1.27 (0.82 to 1.97) 3.69 (1.07 to 12.77)* 1.28 (0.73 to 2.24)
55 years and older 0.96 (0.73 to 1.24) 1.23 (0.78 to 1.92) 2.97 (0.84 to 10.52) 0.99 (0.55 to 1.77)
Educational level
Low 1.00 1.00 1.00 1.00
Moderate 1.30 (1.02 to 1.65)* 1.26 (0.87 to 1.83) 1.20 (0.55 to 2.63) 1.12 (0.70 to 1.79)
High 1.30 (1.03 to 1.64)* 1.02 (0.71 to 1.47) 1.43 (0.70 to 2.91) 0.95 (0.61 to 1.47)
Number of cigarettes per day (CPD)
Less than 10 CPD (light smokers) 1.00 1.00 1.00 1.00
10 or more CPD (moderate-to-heavy smokers) 0.64 (0.53 to 0.79)*** 0.44 (0.32 to 0.59)*** 0.89 (0.43 to 1.82) 1.89 (1.15 to 3.09)*
Survey wave
1—September 2010 1.00 – 1.00 1.00
2—December 2010 1.02 (0.87 to 1.19) 1.00 0.83 (0.45 to 1.54) 0.91 (0.64 to 1.28)
3—March 2011 1.33 (1.13 to 1.56)*** 1.81 (1.43 to 2.28)*** 0.97 (0.50 to 1.86) 1.40 (0.99 to 1.97)
4—June 2011 1.47 (1.24 to 1.74)*** 2.19 (1.70 to 2.81)*** 0.76 (0.37 to 1.56) 1.43 (0.98 to 2.09)
Awareness of the reimbursement policy
No 1.00 1.00 1.00 1.00
Yes 1.08 (0.93 to 1.25) 1.12 (0.89 to 1.42) 2.40 (1.47 to 3.95)*** 1.04 (0.76 to 1.42)
Attention to media coverage about the
reimbursement policy†
1.18 (1.10 to 1.27)*** 1.20 (1.07 to 1.33)** 1.20 (0.97 to 1.47) 1.11 (0.94 to 1.31)
*p<0.05, **p<0.01, ***p<0.001.
†On a scale from 0 to 3.
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was statistically significant (p<0.001). When only taking into
account the smokers who attempted to quit smoking, 32%
reported to be still quit at wave 2, 43% at wave 3 and 52% at
wave 4. Again, the increase between wave 2 and wave 3 was
statistically significant (p=0.007).
Table 2 shows the GEE analysis for all smokers (including
those who did not attempt to quit smoking) that confirmed that
quit success increased significantly between wave 2 and wave 3
(OR=1.81, 95% CI 1.43 to 2.28) and between wave 2 and
wave 4 (OR=2.19, 95% CI 1.70 to 2.81). Attention to media
about the reimbursement policy was significantly associated with
more quit success (OR=1.20, 95% CI 1.07 to 1.33).
An additional GEE analysis (table 3) showed that there were
no significant interactions of number of CPD with the survey
waves or with the awareness/attention variables.
Use of cessation treatment
Use of reimbursed cessation treatment (pharmacological therapy
with behavioural counselling or behavioural counselling only)
remained stable at 1% use or lower of all smokers across waves
(table 1). When examining all smokers, use of unreimbursed
treatment (pharmacological therapy without behavioural
counselling) significantly increased from 2% at wave 2 to 3% at
wave 3 (p=0.025). When examining only smokers who
attempted to quit smoking, the increase from 17% to 19% was
not statistically significant.
The GEE analysis in table 2 confirmed that use of reimbursed ces-
sation treatment among all smokers (including those who did not
attempt to quit smoking) did not change between waves. This was
shown when using wave 1 as a reference category (table 2) and with
wave 2 as reference category (not shown in tables). Awareness of the
reimbursement policy was significantly associated with more use of
reimbursed treatment (OR=2.40, 95% CI 1.47 to 3.95).
Use of unreimbursed cessation treatment among all smokers did
not increase when using wave 1 as a reference category (table 2).
However, with wave 2 as reference category (not shown in tables),
a statistically significant increase in use of unreimbursed treatment
between wave 2 and wave 3 (OR=1.55, 95% CI 1.10 to 2.18) and
between wave 2 and wave 4 (OR=1.58, 95% CI 1.07 to 2.33) was
found. Awareness of the reimbursement policy and attention to
media coverage about the policy were not significantly associated
with use of unreimbursed cessation treatment.
Additional analyses (table 3), using wave 1 as a reference cat-
egory, revealed that there was a significant interaction between
Table 3 Generalised estimating equations analyses of predictors of attempts to quit smoking, quit success, use of reimbursed treatment and













OR (95% CI) n=1906
Gender
Male 1.00 1.00 1.00 1.00
Female 1.18 (0.98 to 1.42) 1.13 (0.84 to 1.53) 1.00 (0.61 to 1.63) 0.95 (0.66 to 1.38)
Age group
18–39 years old 1.00 1.00 1.00 1.00
40–54 years old 1.26 (0.97 to 1.63) 1.27 (0.82 to 1.97) 3.34 (1.16 to 9.57)* 1.33 (0.76 to 2.33)
55 years and older 0.96 (0.74 to 1.25) 1.23 (0.78 to 1.92) 2.96 (1.03 to 8.48)* 1.02 (0.57 to 1.82)
Educational level
Low 1.00 1.00 1.00 1.00
Moderate 1.30 (1.02 to 1.65)* 1.27 (0.88 to 1.85) 1.23 (0.64 to 2.35) 1.14 (0.71 to 1.84)
High 1.31 (1.04 to 1.65)* 1.03 (0.71 to 1.48) 1.39 (0.75 to 2.59) 0.97 (0.62 to 1.50)
Number of cigarettes per day (CPD)
Less than 10 CPD (light smokers) 1.00 1.00 1.00 1.00
10 or more CPD (moderate-to-heavy smokers) 0.52 (0.39 to 0.68)*** 0.39 (0.23 to 0.65)*** 0.57 (0.19 to 1.69) 1.11 (0.54 to 2.28)
Survey wave
1—September 2010 1.00 – 1.00 1.00
2—December 2010 0.93 (0.72 to 1.20) 1.00 1.12 (0.34 to 3.71) 0.85 (0.45 to 1.59)
3—March 2011 1.02 (0.77 to 1.34) 1.44 (1.04 to 1.98)* 0.71 (0.17 to 2.93) 0.53 (0.19 to 1.52)
4—June 2011 1.22 (0.92 to 1.61) 1.75 (1.21 to 2.52)** 0.47 (0.09 to 2.44) 0.44 (0.14 to 1.38)
Awareness of the reimbursement policy
No 1.00 1.00 1.00 1.00
Yes 1.18 (0.88 to 1.58) 1.46 (1.01 to 2.11)* 3.91 (1.35 to 11.33)* 0.57 (0.19 to 1.72)
Attention to media coverage about the reimbursement
policy†
1.09 (0.96 to 1.24) 1.19 (1.00 to 1.41) 0.69 (0.37 to 1.31) 1.29 (0.83 to 2.00)
Interactions
CPD * survey wave 2 1.32 (0.93 to 1.88) 1.49 (0.90 to 2.48) 0.63 (0.14 to 2.70) 1.09 (0.52 to 2.30)
CPD * survey wave 3 1.48 (1.06 to 2.08)* 1.51 (0.95 to 2.39) 1.23 (0.25 to 6.14) 3.11 (1.03 to 9.46)*
CPD * survey wave 4 1.14 (0.83 to 1.58) – 1.46 (0.23 to 9.15) 3.87 (1.15 to 13.02)*
CPD * awareness of the reimbursement policy 0.87 (0.62 to 1.23) 0.65 (0.40 to 1.04) 0.76 (0.22 to 2.60) 1.93 (0.61 to 6.10)
CPD * attention to media coverage about the
reimbursement policy
1.11 (0.95 to 1.30) 1.01 (0.81 to 1.26) 2.22 (1.11 to 4.47)* 0.83 (0.52 to 1.34)
*p<0.05, **p<0.01, ***p<0.001.
†On a scale from 0 to 3.
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number of CPD (light vs moderate-to-heavy smokers) and atten-
tion to media about the reimbursement policy (OR=2.22, 95%
CI 1.11 to 4.47) on use of reimbursed treatment. Stratified ana-
lyses (not shown in tables) showed that attention to media
coverage was positively associated with use of reimbursed treat-
ment among moderate-to-heavy smokers, but not among light
smokers. There was also a significant interaction of number of
CPD with survey wave 3 (OR=3.11, 95% CI 1.03 to 9.46) and
an interaction with survey wave 4 (OR=3.87, 95% CI 1.15 to
13.02). Stratified analyses revealed that use of unreimbursed
treatment increased significantly between waves 1 and 3 and
between waves 1 and 4 among moderate-to-heavy smokers, but
not among light smokers.
DISCUSSION
Previous research has shown that the introduction of the Dutch
national reimbursement policy in 2011 was followed by a statistic-
ally significant decrease in smoking prevalence.22 Our study
reveals that this was due to an increase in quit attempts among
moderate-to-heavy smokers and an increase in quit success among
all smokers. Our findings further suggest that the increase in
smoking cessation can, at least partly, be ascribed to the media
attention that accompanied the policy implementation. Attention
to media about the reimbursement was significantly associated
with more quit attempts and more quit success. Earlier studies
reported more use of cessation treatment and methods in 2011: a
more than 10-fold increase in telephonic counselling11 and a
doubling of the number of prescription medications for smoking
cessation22 in 2011 compared with 2010. The largest increases
were found in the second half of 2011 when it was made known
by the government that, due to budget cuts, the period of reim-
bursement would end in December 2011 and more people had
already spent their yearly mandatory deductible for their health
insurance costs. Our study was restricted to the first 6 months after
policy implementation and showed that the percentage of smokers
who participated in behavioural counselling did not yet increase in
this timeframe, while use of pharmacological therapy without
behavioural counselling (not reimbursed) increased among
moderate-to-heavy smokers. A possible explanation is that it was
not communicated clearly enough that smokers could only get a
reimbursement when they also participated in behavioural coun-
selling. Although the use of pharmacological therapy increased,
the level of use was still quite low after the implementation (3% of
all smokers used pharmacological therapy without behavioural
counselling and 1% used the combination or behavioural counsel-
ling only). This is comparable with findings from the UK, where
only 8% of all smokers use the Stop Smoking Services that are free
of charge.4
The media campaign that was meant to communicate about
the reimbursement policy also showed smokers that it was pos-
sible for them to quit smoking. Light smokers may not have
immediately thought that they needed cessation treatment to
quit smoking, while moderate-to-heavy smokers felt that they
needed this support in order to successfully quit when they had
heard about cessation treatment in the campaign or in other
media. The Dutch media campaign is an example of a
‘how-to-quit’ campaign. In the international literature, there is
not much support for the effectiveness of these kinds of cam-
paigns.23 24 In general, media campaigns in other countries have
shown to be more effective in stimulating quitting when they
elicit negative emotions and describe the negative health conse-
quences of smoking (‘why-to-quit’ campaigns). Possibly, the
Dutch campaign was effective because it was combined with the
implementation of new tobacco policy.25 26
Although the use of reimbursed cessation treatment did not
increase, awareness of the reimbursement policy was signifi-
cantly associated with more use of reimbursed treatment. These
results can possibly be explained by reversed causality; respon-
dents who were using reimbursed treatment were, as a result of
that, more aware of the reimbursement policy. Furthermore,
there was an increase in use of unreimbursed treatment among
moderate-to-heavy smokers, but awareness/attention variables
were not associated with use of unreimbursed treatment.
Therefore, we cannot be sure that the increase in unreimbursed
treatment was a consequence of the reimbursement policy and/
or the accompanying media attention.
A limitation of our study is that less than half of respondents
participated in all four survey waves. Respondents who were
lost to follow-up were younger and more often had a moderate
educational level than respondents who did participate in
follow-up waves. Therefore, our results may not be fully gener-
alisable to the Dutch population of smokers. Furthermore, we
relied on self-reported smoking status to assess quit success.
Respondents who reported an attempt to quit and who indi-
cated that they were still quit at the time of the survey were con-
sidered successful quitters. However, some of them may have
been quit for only a short period of time and may have relapsed
soon after the survey.
Our survey design with four survey waves enabled us to separ-
ate trends before the interventions from changes after the inter-
ventions. However, other events that were not taken into
account in this study could also have caused the observed
effects. Although New Year’s resolutions seem to be a possible
alternative explanation for the increase in quit attempts, our
data show that the increase was sustained long after the first few
months of the year. This strengthens the idea that the reimburse-
ment policy and accompanying media attention were at least
partly responsible for the increase in attempts to quit smoking.
Based on the findings from our study, we recommend that
countries implement a national reimbursement policy for
smoking cessation treatment with accompanying media atten-
tion. The media attention is important to increase awareness of
the reimbursement policy and can possibly also act as a trigger
to stimulate smoking cessation. An intensive mass media cam-
paign such as the one in the Netherlands that reached 80% of
smokers,13 is recommended. Care should be taken to develop
media messages that do not discourage people to quit without
the use of cessation treatment.27 Media should encourage
attempts to quit smoking and the use of evidence-based cessa-
tion treatment for those who have more difficulty to quit.
What this paper adds
▸ A national reimbursement policy in the Netherlands in 2011
that was accompanied by media attention was followed by
an increase in quit attempts among moderate-to-heavy
smokers and an increase in quit success among all smokers.
▸ It seems that the increase in quit attempts and quit success
can (partly) be ascribed to the media attention about the
reimbursement policy.
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